Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 75 | 0 | 12 | 0 | €832.00 | €831.01 | -0.119% |
| Vertex Pharmaceuticals Inc. | 59 | 2 | 2 | 0 | €416.35 | €450.36 | 8.170% |
| Boston Scientific | 55 | 0 | 4 | 0 | €75.00 | €78.31 | 4.408% |
| Regeneron Pharmaceuticals Inc. | 48 | 1 | 4 | 0 | €1,018.5 | €1,087.6 | 6.780% |
| Alnylam Pharmace. | 45 | 0 | 5 | 0 | €246.40 | €275.25 | 11.709% |
| Insmed Inc. | 45 | 0 | 2 | 0 | €67.00 | €77.15 | 15.149% |
| UnitedHealth Group Inc. | 45 | 1 | 4 | 0 | €516.40 | €546.99 | 5.924% |
| Neurocrine Bioscience | 42 | 0 | 4 | 0 | €107.00 | €155.89 | 45.692% |
| Tenet Healthcare | 41 | 0 | 0 | 0 | €149.00 | €154.91 | 3.968% |
| HCA Holdings Inc. | 40 | 0 | 1 | 0 | €359.00 | €359.19 | 0.053% |
| Johnson & Johnson | 41 | 1 | 5 | 0 | €146.86 | €193.18 | 31.539% |
| Intuitive Surgical Inc | 37 | 0 | 3 | 0 | €433.45 | €423.87 | -2.210% |
| Intra-Cellular Therapies Inc. | 35 | 0 | 5 | 0 | €69.00 | €85.00 | 23.188% |
| Cytokinetics Inc. | 36 | 1 | 6 | 0 | €49.00 | €83.06 | 69.505% |
| Acadia Pharmaceuticals | 36 | 1 | 1 | 0 | €14.72 | €29.92 | 103.299% |
| Thermo Fisher Scientific Inc. | 35 | 0 | 6 | 0 | €549.30 | €582.32 | 6.012% |
| Edwards Lifesciences Corp. | 35 | 1 | 3 | 0 | €59.65 | €82.91 | 38.991% |
| AbbVie Inc. | 34 | 0 | 1 | 0 | €172.86 | €180.90 | 4.653% |
| Stryker Corp. | 33 | 0 | 4 | 0 | €327.20 | €342.93 | 4.807% |
| Jazz Pharmaceuticals plc | 32 | 0 | 2 | 0 | €98.72 | €183.41 | 85.793% |
| Merck & Co. Inc. | 32 | 1 | 2 | 0 | €104.60 | €126.38 | 20.822% |
| Centene Corp. | 29 | 0 | 5 | 0 | €67.78 | €82.28 | 21.399% |
| Illumina Inc. | 33 | 4 | 3 | 0 | €117.98 | €158.42 | 34.280% |
| BioMarin Pharmaceutical Inc. | 29 | 0 | 12 | 0 | €63.22 | €100.74 | 59.345% |
| Amgen Inc. | 28 | 0 | 1 | 0 | €303.30 | €304.82 | 0.501% |